OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 75 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,205 | +237.0% | 1,636 | +146.4% | 0.00% | – |
| Q2 2023 | $5,996 | +28.6% | 664 | -50.6% | 0.00% | – |
| Q1 2023 | $4,664 | +173.4% | 1,344 | +93.1% | 0.00% | – |
| Q4 2022 | $1,706 | +70.6% | 696 | +96.6% | 0.00% | – |
| Q3 2022 | $1,000 | -93.8% | 354 | -91.0% | 0.00% | – |
| Q2 2022 | $16,000 | -96.5% | 3,933 | -96.4% | 0.00% | – |
| Q1 2022 | $463,000 | -91.2% | 108,645 | -80.7% | 0.00% | – |
| Q4 2021 | $5,268,000 | -68.5% | 562,854 | -7.3% | 0.00% | -100.0% |
| Q3 2021 | $16,730,000 | -7.0% | 607,051 | -5.6% | 0.00% | 0.0% |
| Q2 2021 | $17,984,000 | -17.0% | 642,751 | -1.5% | 0.00% | -50.0% |
| Q1 2021 | $21,656,000 | -31.2% | 652,697 | -0.3% | 0.00% | -33.3% |
| Q4 2020 | $31,468,000 | – | 654,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $35,043,000 | 3.61% |
| BVF INC/IL | 7,411,503 | $69,372,000 | 2.52% |
| Kynam Capital Management, LP | 293,799 | $2,750,000 | 1.47% |
| Cormorant Asset Management, LP | 2,169,871 | $20,310,000 | 1.21% |
| VR Adviser, LLC | 816,651 | $7,644,000 | 1.04% |
| Vivo Capital, LLC | 1,689,515 | $15,814,000 | 0.95% |
| Octagon Capital Advisors LP | 231,417 | $2,166,000 | 0.42% |
| HighVista Strategies LLC | 50,942 | $477,000 | 0.38% |
| RA Capital Management | 2,150,404 | $20,128,000 | 0.36% |
| Rhenman & Partners Asset Management AB | 500,000 | $4,700,000 | 0.31% |